8/11/2019 IJNSchecklist2 (1)

1/5

IJNS AUTHOR CHECKLISTAuthors of all papers should submit this checklist together with their manuscript. The checklist will be made availabduring the submission process online to all authors and full step-by-step guidance given.

Part 1identifies basic requirements for the manuscript submission (mandatory for all submissions)

Part 2identifies recognized guidelines for scientific reporting, which you should use to prepare your manuscript (required for systematic reviews and originaresearch)

Part 3 Is a self assessment checklist that is designed to help to ensure that your research or review manuscript meets basic standards and the journals Gufor Authors(optional only)

PART 1 Basic

reuirements

Author response or further detail Tick

!ord count

!as ethical approvalgiven and bywhom" #giveany referencenumber$

%lease state anyconflicts ofinterest

%lease state sourcesof funding andthe role offunders in theconduct of theresearch

%lease state anystudy registrynumber #egI&'()*$

)itle )he title is in the format +)opic question- designtype of paper and identifies the population care setting studied(e.g. The effectiveness of telephone support for adolescents with insulin dependant

diabetes controlled before and after study the structure is optional for discussion papers,editorials and commentaries)

Abstract A structured abstract appropriate to the design #see guidelines for authors) 'eports ofcontrolled trials should follow the (.*&.') format #does not apply to editorials orcommentaries, Abstracts for discussion papers need not be structured$

/ey words 0etween four and ten key words have been provided in alphabetical order, which accuratelyidentify the paper1s subject, purpose, method and focus 2se the 3edical &ubject 4eadings#3e&45$ thesaurus or (umulative Inde6 to *ursing and Allied 4ealth #(I*A47$ headingswhere possible #seehttp-wwwnlmnihgovmeshmeshhomehtml$

4ighlights 0ullet points have been included that identify e6isting research knowledge relating to thespecific research question topic #what is already known$ and a summary of the new

knowledge added by this study #what the paper adds$ (see !uide for "uthors, does notapply to editorials or commentaries$

'eferences (itations accord to the journals format #Author, date$ and reference list includes full detailsof all cited references in the proper format and alphabetical order #see !uide for "uthors)

.ther %ublishedaccounts

"llpublished and in press accounts of the study from which data in this paper originate arereferred to in the paper and the relationship between this and other publications from thesame study is made clear#see !uide for "uthors$

http://www.nlm.nih.gov/mesh/meshhome.htmlhttp://www.nlm.nih.gov/mesh/meshhome.htmlhttp://www.nlm.nih.gov/mesh/meshhome.html

8/11/2019 IJNSchecklist2 (1)

2/5

)he study is referred to by a distinctive name which will be used in any future publicationsto identify that it as the same study

%lease upload copies of all previous, current and under review publications from this studyand or give full details below

Authorship All authors and contributors sufficiently acknowledged as per Guide for Authors

8/11/2019 IJNSchecklist2 (1)

3/5

PART !"tandards ofreporting

)he editors require that manuscripts adhere to recognized reporting guidelines relevant to theresearch design used )hese identify matters that should be addressed in your paper %leaseindicate which guidelines you have referred to

)hese are not quality assessment frameworks and your study need not meet all the criteriaimplied in the reporting guideline to be worthy of publication in the I8*& )he checklists doidentify essential matters that should be considered and reported upon 9or e6ample, acontrolled trial may or may not be blinded but it is important that the paper identifies whether ornot participants, clinicians and outcome assessors were aware of treatment assignments

::;ou are encouraged #although not required$ to submit a checklist from the appropriatereporting guideline together with your paper as a guide to the editors and reviewers of your

paper

#eporting guidelines endorsed by the $%&' are listed below

uidelinere!erredto

Checkli"t"u#$itted

%

%

.bservational cohort,case control andcross sectionalstudies

&)'.0< Strengthening the Reporting of O#servational &tudies in Epidemiologyhttp-wwwequator=networkorginde6asp6"o>?@B

Cuasi e6perimental non=randomizedevaluations

)'?@B

&ystematic 'eview of(ontrolled )rials

%'I&3A = %referred 'eporting Items for &ystematic 'eviews and 3eta=Analyseshttp-wwwequator=networkorginde6asp6"o>?@B

&ystematic 'eview of.bservational&tudies

3..&< 3eta=analysis of .bservational &tudies in

8/11/2019 IJNSchecklist2 (1)

4/5

PART # Part # "elf-assessment checklist for research and reviews $optional%

;ou might like to review the content of your paper before submission to ensure that the essentialelements are present !e do not intend that this checklist should dictate sub headings that you mustuse #although you might find it useful$ but rather give a guide to content and issues that should #ingeneral$ always be considered ;ou might find it helpful to note the page number where some of thekey issues are dealt with to assist reviewers

"ection &escriptor T'()

a$ &ri$ar' re"earch onl'

0ackground A statement of the problem phenomena of interest, a brief summary of e6isting researchwhich addresses the topic and an e6planation of the purpose of the current study review inrelation to this

*+T,&" (lear statement of the aims, objectives #hypothesis$ and research design

&ettings )he settings and locations where the study took place

Inclusion (riteria

8/11/2019 IJNSchecklist2 (1)

5/5

PART # "elf-assessment checklist for research and reviews

"ection &escriptor T'()

b$ Re)ie*" onl'

0ackground A statement of the problem phenomena of interest, a brief summary of e6isting researchwhich addresses the topic and an e6planation of the purpose of the current study review inrelation to this

+ETHO(S